These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 26861471)
1. The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain. Pope JE; Deer TR; Amirdelfan K; McRoberts WP; Azeem N Curr Neuropharmacol; 2017; 15(2):206-216. PubMed ID: 26861471 [TBL] [Abstract][Full Text] [Related]
2. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study. Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287 [TBL] [Abstract][Full Text] [Related]
3. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain. Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508 [TBL] [Abstract][Full Text] [Related]
4. Ziconotide: an update and review. Williams JA; Day M; Heavner JE Expert Opin Pharmacother; 2008 Jun; 9(9):1575-83. PubMed ID: 18518786 [TBL] [Abstract][Full Text] [Related]
5. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507 [TBL] [Abstract][Full Text] [Related]
6. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review. Klotz U Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978 [TBL] [Abstract][Full Text] [Related]
8. Intrathecal pain pumps: indications, patient selection, techniques, and outcomes. Bolash R; Mekhail N Neurosurg Clin N Am; 2014 Oct; 25(4):735-42. PubMed ID: 25240660 [TBL] [Abstract][Full Text] [Related]
9. Intrathecal therapy: what has changed with the introduction of ziconotide. Kress HG; Simpson KH; Marchettini P; Ver Donck A; Varrassi G Pain Pract; 2009; 9(5):338-47. PubMed ID: 19740270 [TBL] [Abstract][Full Text] [Related]
11. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects. Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373 [TBL] [Abstract][Full Text] [Related]
12. Ziconotide: A rapid detoxification protocol for the conversion from intrathecal morphine--the Raffaeli Detoxification Model. Raffaeli W; Righetti D; Sarti D; Balestri M; Ferioli I; Monterubbianesi MC; Caminiti A J Opioid Manag; 2011; 7(1):21-6. PubMed ID: 21434581 [TBL] [Abstract][Full Text] [Related]
13. Intrathecal ziconotide for neuropathic pain: a review. Rauck RL; Wallace MS; Burton AW; Kapural L; North JM Pain Pract; 2009; 9(5):327-37. PubMed ID: 19682321 [TBL] [Abstract][Full Text] [Related]
14. Intrathecal Pharmacology Update: Novel Dosing Strategy for Intrathecal Monotherapy Ziconotide on Efficacy and Sustainability. Pope JE; Deer TR Neuromodulation; 2015 Jul; 18(5):414-20. PubMed ID: 25708382 [TBL] [Abstract][Full Text] [Related]
15. Ziconotide: a clinical update and pharmacologic review. Pope JE; Deer TR Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340 [TBL] [Abstract][Full Text] [Related]
16. Bolus intrathecal injection of ziconotide (PrialtĀ®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study. Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options. Deer TR; Pope JE; Hanes MC; McDowell GC Pain Med; 2019 Apr; 20(4):784-798. PubMed ID: 30137539 [TBL] [Abstract][Full Text] [Related]
18. A safety review of approved intrathecal analgesics for chronic pain management. Chalil A; Staudt MD; Harland TA; Leimer EM; Bhullar R; Argoff CE Expert Opin Drug Saf; 2021 Apr; 20(4):439-451. PubMed ID: 33583318 [No Abstract] [Full Text] [Related]
19. Discussion forum. Eisenberg E J Pain Palliat Care Pharmacother; 2007; 21(3):71-2. PubMed ID: 18032361 [TBL] [Abstract][Full Text] [Related]
20. Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain. McDowell GC; Pope JE Neuromodulation; 2016 Jul; 19(5):522-32. PubMed ID: 26856969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]